These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043 [TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417 [TBL] [Abstract][Full Text] [Related]
4. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Sarver AL; Li L; Subramanian S Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966 [TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. Zou F; Mao R; Yang L; Lin S; Lei K; Zheng Y; Ding Y; Zhang P; Cai G; Liang X; Liu J FEBS J; 2016 Apr; 283(8):1438-52. PubMed ID: 26859226 [TBL] [Abstract][Full Text] [Related]
8. FOXP3 Controls an miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells. Liu R; Liu C; Chen D; Yang WH; Liu X; Liu CG; Dugas CM; Tang F; Zheng P; Liu Y; Wang L Cancer Res; 2015 Apr; 75(8):1703-13. PubMed ID: 25712342 [TBL] [Abstract][Full Text] [Related]
9. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation. Burger ML; Xue L; Sun Y; Kang C; Winoto A Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967 [TBL] [Abstract][Full Text] [Related]
11. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas. Zappasodi R; Cavanè A; Iorio MV; Tortoreto M; Guarnotta C; Ruggiero G; Piovan C; Magni M; Zaffaroni N; Tagliabue E; Croce CM; Zunino F; Gianni AM; Di Nicola M Int J Cancer; 2014 Nov; 135(9):2034-45. PubMed ID: 24648290 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260 [TBL] [Abstract][Full Text] [Related]
13. Limited miR-17-92 overexpression drives hematologic malignancies. Danielson LS; Reavie L; Coussens M; Davalos V; Castillo-Martin M; Guijarro MV; Coffre M; Cordon-Cardo C; Aifantis I; Ibrahim S; Liu C; Koralov SB; Hernando E Leuk Res; 2015 Mar; 39(3):335-41. PubMed ID: 25597017 [TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073 [TBL] [Abstract][Full Text] [Related]
15. Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis. Ding L; Zhang Y; Han L; Fu L; Mei X; Wang J; Itkow J; Elabid AEI; Pang L; Yu D Oncogene; 2018 Mar; 37(10):1293-1307. PubMed ID: 29284789 [TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from miR-146a-modified adipose-derived stem cells attenuate acute myocardial infarction-induced myocardial damage via downregulation of early growth response factor 1. Pan J; Alimujiang M; Chen Q; Shi H; Luo X J Cell Biochem; 2019 Mar; 120(3):4433-4443. PubMed ID: 30362610 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of miR-146a in myasthenia gravis. Lu J; Yan M; Wang Y; Zhang J; Yang H; Tian FF; Zhou W; Zhang N; Li J Neurosci Lett; 2013 Oct; 555():85-90. PubMed ID: 24036458 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas. Jeong D; Kim J; Nam J; Sun H; Lee YH; Lee TJ; Aguiar RC; Kim SW Leukemia; 2015 Sep; 29(9):1868-74. PubMed ID: 25915824 [TBL] [Abstract][Full Text] [Related]
19. AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo. Devlin JR; Hannan KM; Ng PY; Bywater MJ; Shortt J; Cullinane C; McArthur GA; Johnstone RW; Hannan RD; Pearson RB FEBS J; 2013 Nov; 280(21):5307-16. PubMed ID: 23331925 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]